EichorEICHOR
Location: Madera Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Madera

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Valley Children's Hospital · National Cancer Institute (NCI) · NCT06172296
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Valley Children's Hospital · National Cancer Institute (NCI) · NCT05691478
PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal
Phase N/A · Portuguese Association of Interventional Cardiology · NCT07343674
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Valley Children's Hospital · Children's Hospital of Philadelphia · NCT02708134
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Valley Children's Hospital · Children's Oncology Group · NCT04322318
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Phase N/A · Valley Children's Healthcare · Novartis Pharmaceuticals · NCT04174157
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT04293562
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescent
Phase 2 · Valley Children's Hospital · National Cancer Institute (NCI) · NCT06900595
Uterine Junctional Zone and Its Relation to Adverse Obstetrical Outcomes in Assisted Reproductive Technology
Phase N/A · Centro Hospitalar Lisboa Norte · NCT05763498
Project: Every Child for Younger Patients With Cancer
Phase N/A · Valley Children's Hospital · Children's Oncology Group · NCT02402244
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT05235165
I-DECIDE After Bronchiolitis Hospitalization
NA · Valley Children's Hospital · Seattle Children's Hospital · NCT07243652
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an An
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT06647953
Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia
Phase 4 · Hospital Central do Funchal · NCT07386353
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Valley Children's Hospital · National Cancer Institute (NCI) · NCT05675410
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT07022678
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acu
Phase 2 · Valley Children's Hospital · National Cancer Institute (NCI) · NCT04546399
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Ove
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT07466316
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atr
Phase 4 · Valley Children's Hospital · Hoffmann-La Roche · NCT05861999
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years
Phase 3 · Research Site · AstraZeneca · NCT06307665
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Phase 3 · Lumos Pharma Investigational Site · Lumos Pharma · NCT06948214
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Phase 2 · Valley Children's Hospital · Children's Oncology Group · NCT04684368
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT03067181
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
NA · Valley Children's Hospital · Johns Hopkins University · NCT04989790
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histioc
Phase 2 · Valley Children's Hospital · National Cancer Institute (NCI) · NCT05828069
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT06401330
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Phase 3 · Valley Children's Hospital · Children's Oncology Group · NCT05382338
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · Valley Children's Hospital · Novo Nordisk A/S · NCT06612268
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatme
Phase N/A · Valley Children's Hospital · Children's Oncology Group · NCT01790152
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Phase 1/Phase 2 · Valley Children's Hospital · Tanja Andrea Gruber · NCT05848687
Look up another city
Look up another condition